Exozymes says optimized NCT process lifts manufacturing productivity 10-fold

Exozymes reported an optimized N-trans-caffeoyltyramine (NCT) process that lifted manufacturing productivity by 10x versus its earlier pilot-scale baseline.

• NCT output rose about 67% per liter versus the prior 100-liter pilot run, supporting higher commercial-scale throughput.
• Reaction time fell more than 80%, improving time-in-tank economics and capacity utilization for future manufacturing partners.
• Internal cost assessments show estimated manufacturing cost equivalent down more than 100x from the first NCT process version.
• Focus shifted to simplifying operations and preparing technology transfer to commercial partners to move from pilot validation toward scalable production.